NKp80/KLRF1 Antibody (MM0492-7D32) [DyLight 650]
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-11821C
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Human
Applications
CyTOF-ready, Flow Cytometry
Label
DyLight 650 (Excitation = 652 nm, Emission = 672 nm)
Antibody Source
Monoclonal Rat IgG2 Clone # MM0492-7D32
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Human recombinant NKp80/KLRF1
Clonality
Monoclonal
Host
Rat
Isotype
IgG2
Description
This conjugate is made on demand. Actual recovery may vary from the stated volume of this product. The volume will be greater than or equal to the unit size stated on the datasheet.
Applications for NKp80/KLRF1 Antibody (MM0492-7D32) [DyLight 650]
Application
Recommended Usage
CyTOF-ready
Optimal dilutions of this antibody should be experimentally determined.
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein G purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: NKp80/KLRF1
Alternate Names
CLEC5C, KLRF1
Gene Symbol
KLRF1
Additional NKp80/KLRF1 Products
Product Documents for NKp80/KLRF1 Antibody (MM0492-7D32) [DyLight 650]
Product Specific Notices for NKp80/KLRF1 Antibody (MM0492-7D32) [DyLight 650]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...